Germany · Biopharma startup

pluriSelect

pluriSelect offers separation technologies for the isolation of cells, proteins, viruses, and bacteria from blood and biological fluids.

Funding reportedLast round: Undisclosed round

BiopharmaLeipzig, Germany

What company datasets say pluriSelect raised

Funding, as reported

Reported in all780kin the source's currency
Rounds1
Last roundUndisclosed round
Last round dateMar 2009
Investors listed3

Biopharma in Germany

Startups like it

Is this your company?

Add your raise, your deck and your story, and put pluriSelect in front of investors. Or tell us what we have wrong.